scholarly journals Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives

2019 ◽  
Vol Volume 10 ◽  
pp. 373-384 ◽  
Author(s):  
Osman Ozel ◽  
Caila B Vaughn ◽  
Svetlana P Eckert ◽  
Dejan Jakimovski ◽  
Alexis A Lizarraga ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Multiple Sclerosis Patient ◽  
Patient Reported Outcomes ◽  
Dimethyl Fumarate ◽  
Patient Reported ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis

scholarly journals Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Angela E. Williams ◽  
Jeffrey T. Vietri ◽  
Gina Isherwood ◽  
Armando Flor
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Patient Reported Outcomes ◽  
The United States ◽  
Symptom Clusters ◽  
Patient Reported ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis

Background. A variety of symptoms have been reported, but the prevalence of specific symptoms in relapsing-remitting multiple sclerosis (RRMS), how they are related to one another, and their impact on patient reported outcomes is not well understood.Objective. To describe how symptoms of RRMS cooccur and their impact on patient-reported outcomes.Methods. Individuals who reported a physician diagnosis of RRMS in a large general health survey in the United States indicated the symptoms they experience because of RRMS and completed validated scales, including the work productivity and activity impairment questionnaire and either the SF-12v2 or SF-36v2. Symptom clusters were identified through hierarchical cluster analysis, and the relationship between clusters and outcomes was assessed through regression.Results. Fatigue, difficulty walking, and numbness were the most commonly reported symptoms. Seven symptom clusters were identified, and several were significantly related to patient reported outcomes. Pain, muscle spasms, and stiffness formed a cluster strongly related to physical quality of life; depression was strongly related to mental quality of life and cognitive difficulty was associated with work impairment.Conclusions. Symptoms in RRMS show a strong relationship with quality of life and should be taken into consideration in treatment decisions and evaluation of treatment success.

scholarly journals Dimethyl fumarate for relapsing-remitting multiple sclerosis

2014 ◽  
Vol 13 (11) ◽  
pp. 1077-1078
Author(s):  
Martyn J Burke ◽  
Joanna Richardson ◽  
Elisabeth George ◽  
Amanda I Adler
Keyword(s):  
Multiple Sclerosis ◽  
Dimethyl Fumarate ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis
Sign in / Sign up

Export Citation Format

Share Document